2016
DOI: 10.1038/eye.2016.205
|View full text |Cite
|
Sign up to set email alerts
|

Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine–Gass syndrome: a prospective case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 29 publications
0
8
0
1
Order By: Relevance
“…Eighteen studies with a mean sample size of 19 eyes (range 3 to 59) met the prespecified inclusion criteria and were included in this systematic literature review. 10–27 Table 2 demonstrates the characteristics of each, consisting of 2 randomized controlled trials, 5 prospective case series, and 11 retrospective case series. The treatment groups represented in the studies were intravitreal steroid injections, intravitreal vascular endothelial growth factor inhibitor injections, intravitreal tumor necrosis factor alpha inhibitor injections, posterior sub-Tenon steroid injections, and intravitreal steroid implants.…”
Section: Resultsmentioning
confidence: 99%
“…Eighteen studies with a mean sample size of 19 eyes (range 3 to 59) met the prespecified inclusion criteria and were included in this systematic literature review. 10–27 Table 2 demonstrates the characteristics of each, consisting of 2 randomized controlled trials, 5 prospective case series, and 11 retrospective case series. The treatment groups represented in the studies were intravitreal steroid injections, intravitreal vascular endothelial growth factor inhibitor injections, intravitreal tumor necrosis factor alpha inhibitor injections, posterior sub-Tenon steroid injections, and intravitreal steroid implants.…”
Section: Resultsmentioning
confidence: 99%
“…The intravitreal dexamethasone implant promising alternative therapy to achieve rapid resolution in recalcitrant post-surgical cystoid macular edema, refractory to topical treatments. It has a relatively better safety pro ile, reduce complications with low recurrence rate [27][28][29].…”
Section: Corticosteroid Treatmentmentioning
confidence: 99%
“…Later, OCT acquired a critical monitoring role during intravitreal anti-VEGF therapy (VEGF: vascular endothelial growth factor) 4 , 5 , 6 . It also enabled very precise assessment of conditions such as diabetic fundus changes, retinal vessel occlusion, uveitis, and Irvine Gass syndrome, as well as monitoring of the patientʼs response to therapy 711 .…”
Section: Introductionmentioning
confidence: 99%
“…Später kam der OCT eine entscheidende Rolle im Monitoring während einer intravitrealen Anti-VEGF-Therapie (VEGF: vascular endothelial growth factor) zu 4 , 5 , 6 . Gleichermaßen ließen sich Makulaödeme im Rahmen von diabetischen Fundusveränderungen, retinalen Gefäßverschlüssen, Uveitiden, des Irvine-Gass-Syndroms u. a. sehr genau beurteilen und ihr Therapieansprechen verfolgen 7 , 8 , 9 , 10 , 11 .…”
Section: Introductionunclassified